Tuesday, October 10, 2017 9:08:13 AM
https://www.otcmarkets.com/stock/GRCK/news/Grey-Cloak-s-Acquisition-Target-Eqova-Exhibits-at-Denver-s-Integrative-Medicine-Summit?id=171998&b=y
Grey Cloak's Acquisition Target Eqova Exhibits at Denver's Integrative Medicine Summit
LAS VEGAS, NV--(Marketwired - Oct 10, 2017) - Grey Cloak Tech Inc. (OTC PINK: GRCK) announced today that Eqova Live Sciences exhibited at Denver's Integrative Medicine Summit in Denver Colorado on October 7, 2017.
Denver's Integrative Medicine Summit is the premier integrative medicine summit in the Rocky Mountain region. The summit featured headlining talks by bestselling author Dr. Jack Wolfson, D.O., FAAC and Dr. Amy Myers, MD as well as Tom O'Bryan DC, CCN, DACBN.
The Summit was attended by over 200 medical professionals, including functional medicine doctors, nutritionists, chiropractors and surgeons.
Eqova Life Sciences was the only company exhibiting CBD based products at the summit and debuted its new CannaBio Salve, an innovative topical salve with several aromatic natural oils.
Patrick Stiles, Eqova's President, said, "I was overwhelmed with the interest in our product line. Clearly the practitioner space is severely underserved, and our clinical brand addresses their concerns about the CBD and Full Spectrum Hemp Oil industry very well.
"The topics of the show were a perfect match for the Eqova line of products. Because of our unique positioning, and serving the practitioners we opened several new accounts."
On September 19, 2017, the Company announced the signing of a Letter of Intent to acquire Eqova Life Sciences. Eqova Life Sciences, located in Denver, Colorado, develops clinical grade Full Spectrum Hemp Oil products, sold exclusively via partnerships with licensed medical practitioners to use with their patients. The Company anticipates completing the acquisition of Eqova within the next 15 days upon the successful completion of due diligence and final acquisition agreements.
Recent HYEX News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:22:30 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 10/24/2023 06:25:27 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 10/06/2023 06:09:39 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/14/2023 05:22:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 06:30:40 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 09/05/2023 08:24:27 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 08/24/2023 08:12:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 09:09:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/17/2023 05:30:59 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM